04
Jun
2020
18:00
BST
Webinar
Transcatheter Aortic Valve Replacement Update in Bicuspid Aortic Valve Disease
-
Views:
18
-
Likes:
0
Overview
‘Transcatheter aortic valve replacement update in bicuspid aortic valve disease’ brings together four international opinion leaders to comprehensively review the latest clinical evidence, evaluate recent trial outcomes, address patient and device selection, and provide practical insight through case reviews.
Designed to best support both cardiologists and surgeons, this engaging one-hour educational programme will be further enhanced through a live Q&A session, to help address some of the most pertinent and challenging questions in clinical practice.
Faculty:
Nicolas M Van Mieghem
Basel Ramlawi
Didier Tchetche
Firas Zahr
This webinar is supported by
Agenda
Learning Objectives
- Describe the latest data in bicuspid valve disease and understand the classifications
- Critically evaluate clinical trial data in TAVR in low-risk bicuspid patients
- Review implant techniques and device considerations for bicuspid patients
Audience
- This programme has been formulated to best support the learnings of cardiologists and surgeons globally.
Faculty Biographies
Nicolas M Van Mieghem
Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010.
He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals.
Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.